- Key strategic appointment as the Company enters next phase of commercial growth and global expansion of its products and services
- Former CEO, Dr David Hughes, appointed to Scientific Advisory Board
News
Click here to view the December 2022 edition of The Meeting Place
Asahi Kasei Pharma offers collaborative research opportunities with research funding and our scientists’ contribution through research activities.
Cambridge, UK, 14 December 2022: PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, and ThinkCyte K.K, a biotechnology company pioneering novel cell analysis and sorting instruments, today announced a strategic research partnership aimed at advancing modern phenotypic drug screening using artificial intelligence (AI).
AMSBIO announce a new range of different isolation products for fast, scalable, and reproducible purification of Extracellular Vesicles (EV), including exosomes, as well as addressing EV heterogeneity and high throughput solutions for biomarker discovery.
ValiRx PLC, a life science company focused on early-stage cancer therapeutics and women's health, has appointed a project manager to lead the preclinical development of its in-licensed triple negative breast cancer treatment, CLX001.
Read the latest People Pathways newsletter for your monthly round up of employee engagement activities.
PRESS RELEASE
PrecisionLife Enters into a Multi Target R&D Collaboration Agreement with Ono Pharmaceutical
- Scott Maidment appointed as Head of HTS to lead the new service
- Expanded facilities gives Company total of 20,160 sq. ft at Granta Park, Cambridge, UK
Research targeted at identifying novel inhibitors or activators of Kv3.1 mutation